Multiple endocrine neoplasia type 2 other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
! style="background: #F5F5F5;" |RET and other genes of interest | ! style="background: #F5F5F5;" |RET and other genes of interest | ||
|} | |} | ||
== | ==References== | ||
{{ | {{reflist|2}} | ||
[[Category:Endocrine system]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Endocrinology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 15:05, 28 September 2015
|
Multiple endocrine neoplasia type 2 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Multiple endocrine neoplasia type 2 other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 other diagnostic studies |
|
FDA on Multiple endocrine neoplasia type 2 other diagnostic studies |
|
CDC on Multiple endocrine neoplasia type 2 other diagnostic studies |
|
Multiple endocrine neoplasia type 2 other diagnostic studies in the news |
|
Blogs on Multiple endocrine neoplasia type 2 other diagnostic studies |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Other diagnostic studies for multiple endocrine neoplasia type 2 include molecular genetic testing which include sequence analysis of select exons of mainly 10,11, 13-16 and sequence analysis of RET gene.
Other Diagnostic Studies
Molecular Genetic Testing
| Test | Method |
|---|---|
| Select exon testing | Sequence analysis of select exons of mainly 10,11, 13-16 |
| Single-gene testing | Sequence analysis of RET gene |
| A multi-gene panel | RET and other genes of interest |